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Abstract 
 
This was a prospective, randomized, double-blind study comparing the effect of remifentanil and fentanyl on 
cardiovascular responses from laryngoscopy and tracheal intubation. Forty-four ASA I or II patients aged between 
18-65 yrs scheduled for elective surgery under general anaesthesia, were recruited and randomized into two groups.  
Each patient in Group R received remifentanil of 0.5 mcg/kg bolus over 30 seconds followed by an infusion of 0.25 
mcg/kg/min and each patient in Group F received fentanyl of 2 mcg/kg bolus over 30 seconds followed by an 
infusion of normal saline. Anaesthesia was then induced with propofol, rocuronium and 2% sevoflurane with 100% 
oxygen. Cardiovascular changes were recorded every minute for 3 minutes after induction and 5 minutes after 
tracheal intubation. The heart rate remained stable throughout the induction and intubation period in both groups. 
None of the patients in the remifentanil group develop bradycardia. Systolic blood pressure (SBP) and mean arterial 
pressure (MAP) were significantly lower in the fentanyl group at the 3rd minute post-induction and 5th minute post-
intubation (p < 0.05). Diastolic blood pressure (DBP) in the fentanyl group was significantly lower at the 2nd and 
3rd minute post-induction and 4th and 5th minute post-intubation (p < 0.05).  The blood pressure remained stable for 
the remifentanil group throughout the induction and intubation period. Six patients (27.2%) in the fentanyl group and 
one patient (4.5%) in the remifentanil group experienced hypertension. Three patients (13.7%) from each group 
experienced hypotensive episodes. In conclusion, remifentanil 0.5 mcg/kg bolus followed by 0.25 mcg/kg/min 
infusion resulted in SBP, MAP and DBP remained slightly lower than baseline throughout the whole period but still 
consider stable, as these changes were not statistically significant. 
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The pressor response to laryngoscopy and tracheal 
intubation, resulting in hypertension and tachycardia, 
is well described (1). Plasma concentrations of 
catecholamines are increased and can lead to 
myocardial ischemia, depression of myocardial 
contractility and ventricular arrhythmias (2).  These 
responses may be attenuated by several methods,  
 
including administration of intravenous opioids 
(fentanyl, alfentanil, sufentanil, remifentanil) (3,4,5,6), 
vasodilators (7,8,9), beta blockers (10,11,12,) local 
anaesthetic agents e.g. lignocaine (13), gabapentin (14) 
or by increasing the depth of anaesthesia. Currently in 
our institution, the drug most commonly used is 
fentanyl of 1 to 3 mcg/kg bolus followed by an 
induction agent and muscle relaxant for laryngoscopy 
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and endotracheal intubation in patients undergoing 
non-cardiac surgeries. 
 
Remifentanil has rapid metabolism by plasma esterase, 
thus is ultrashort-acting and easy to titrate to achieve 
desired plasma levels (15,16,17,18).  Pharmacokinetic 
studies demonstrate that remifentanil has a small 
volume of distribution of 25-30 litres whereas for 
fentanyl is 334 litres. Remifentanil also has a rapid 
distribution phase, total clearance of 4.2-5.0 litre/min, 
a terminal elimination half-life of 10 to 21 minutes, 
context sensitive half time of 4 minutes and half-time 
for equilibrium between the plasma and effect of the 
effect compartment of 1.3 minutes. Clearance of 
remifentanil is not affected by renal or liver disease, 
body weight, sex or age. These properties make 
remifentanil the opioid of choice to obtund noxious 
cardiovascular reflexes during laryngoscopy and 
tracheal intubation. An additional advantage is the 
rapid return of spontaneous respiration and airway 
reflexes.  
 
Many studies have shown that remifentanil is a safe 
drug to be administered as an adjuvant to induction 
(15,16,17,18) as it has minimal adverse cardiovascular 
effects, meaning mild bradycardia and reduced arterial 
blood pressure by 15-20% at larger doses. Thompson 
et al. (1998) investigated the use of remifentanil in 
normal populations (3), elderly (19), patients with 
hypertension (20) and patients with ischemic heart 
disease (21) and found out that remifentanil attenuated 
the pressor response to laryngoscopy and intubation. 
However there was associated bradycardia at a 
standard dosage of 1mcg/kg bolus followed by an 
infusion of 0.5mcg/kg/min and thus the use of a 
concurrent vagolytic agent was suggested. Other 
studies also showed that remifentanil can be used 
safely as an adjuvant therapy for laryngoscopy and 
tracheal intubation in children (22), and in rapid 
sequence induction (23). Remifentanil also acts 
synergistically with propofol to provide excellent 
intubation conditions without the use of muscle 
relaxants (24). 
 
In a later study, Thompson et al. (1996) compared 
different doses of remifentanil on cardiovascular 
responses to laryngoscopy and tracheal intubation 
(15). The same researchers also found out that there 
were no significant differences in haemodynamic 
changes in groups given either in a higher dose (1 
mcg/kg bolus followed by 0.5 mcg/kg/min infusion) or 
lower dose (0.5 mcg/kg bolus followed by 0.25 
mcgkg/min) of remifentanil, but the incidence of 
bradycardia was lower in groups which received a 
lower dose. However, they did not require rescue 
treatment with any vagolytic agent.  
The aim of this study was to compare the effect of 
remifentanil (0.5 mcg/kg bolus followed by 0.25 
mcg/kg/min infusion) and fentanyl (2 mcg/kg bolus 
followed by normal saline infusion) on cardiovascular 
responses, i.e. blood pressure and heart rate changes to 
laryngoscopy and tracheal intubation in patients 
undergoing elective surgery. 
 
Materials and Methods 
 
This was a prospective, randomized, double-blind 
control trial conducted after obtaining institutional 
ethics committee approval where 48 patients aged 
between 18 to 65 years old with ASA physical status I 
or II, scheduled for elective surgeries under general 
anaesthesia with tracheal intubation were recruited 
into the study. Patients with potential airway 
difficulties, significant coronary or airway disease, 
body mass index (BMI) > 30 kg m-2, history of 
alcohol or drug abuse, history of gastro-oesophageal 
reflux, those with hypertension on treatment, or known 
allergies to propofol, opioids or rocuronium, were 
excluded. Sample size was obtained from calculation 
using Power and Sample Size Calculation Software. A 
previous study showed that 20 patients per group 
would be required to demonstrate a difference in mean 
arterial pressure (MAP) of 15 mmHg and heart rate of 
15 beats per minute. With the power of 0.8 and alpha 
value of 0.05, and additional drop up rate of 20%, a 
total of 48 patients were required.  
 
On the day before the scheduled surgery, written 
informed consent was obtained from all patients. They 
were fasted overnight and premedication, i.e. 
midazolam 7.5 mg per patient 7.5mgwas given. They 
were then randomized into two groups (Group R for 
remifentanil and Group F for fentanyl) in a double-
blind manner by computer generated numbers. 
 
Upon arrival in the operation theatre, each patient 
received intravenous Hartmann‟s Solution at 5 ml/kg 
over 5 to 10 minutes before induction of anaesthesia. 
Standard monitoring of heart rate, blood pressure, 
oxygen saturation and ECG were established. Blood 
Pressure was measured non-invasively using Datex 
CardiocapTM and ECG was monitored in the CM5 
position. Heart rate and blood pressure were taken 
before the start of the study as a baseline. 
 
The study drugs were prepared by an independent 
anaesthesiologist or a staff nurse not involved in the 
study and handed to the anaesthesiologist or senior 
medical officer designated to perform laryngoscopy 
and tracheal intubation. Each patient in Group R was 
given 0.5 mcg/kg remifentanil in 10 ml saline over 30 
seconds followed by an infusion at a rate of 0.25 
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mcg/kg/min. Each patient in Group F received 2 
mcg/kg fentanyl diluted in 10ml saline over 30 
seconds followed by an infusion of saline. 
Subsequently anaesthesia was induced with propofol 
at 2.0 mg/kg followed by increments of 10 mg every 
10 seconds as needed until anaesthesia was established 
and rocuronium 0.6 mg/kg was given for 
neuromuscular blockade. Patients were ventilated 
manually with 2% sevoflurane and 100% oxygen, to 
an end-tidal carbon dioxide level of 35-45 mmHg. 
MAC was not standardized. Laryngoscopy was done 
by anaesthesiologist or senior medical officer with 
more than 1 year experience in anaesthesia 3 minutes 
after loss of verbal contact using a Macintosh 
laryngoscope, size 3 blade. An endotracheal tube size 
7.5 mm was used for female patients and 8.0 mm for 
male patients respectively. Intubation was considered 
successful if achieved within 30 seconds in a single 
attempt. Heart rate (HR), systolic blood pressure 
(SBP), mean arterial pressure (MAP) and diastolic 
arterial pressure (DBP) were recorded at 1 minute 
intervals from induction of anaesthesia until 5 minutes 
after intubation. Ephedrine at 3 mg increments was 
administered for hypotension which was defined as a 
drop of systolic blood pressure of less than 90 mmHg 
or a decrease of more than 30% from baseline value 
for more than 60 seconds. For bradycardia which was 
defined as a drop of heart rate to less than 45 beats per 
minute, atropine in 0.5 mg increments would be given 
as needed. Regarding hypertension, defined as SBP of 
more than 200 mmHg or more than 30% above 
baseline for more than 60 seconds, and tachycardia 
defined as heart rate of more than 100 bpm, inspired 
sevoflurane was increased in increments of 0.5% until 
control was achieved. Occurrence of these adverse 
events was recorded. Patients were excluded from the 
study if there was failed intubation within 30 seconds 
or if multiple attempts of intubation were necessary. 
 
Statistical analysis was performed using the Chi-
Square test for baseline characteristics and Wilcoxon 
Signed Rank Test in SPSS Version 18 for 
cardiovascular variables for intra-group and inter-
group comparison.  A p value of <0.05 was considered 




Forty-eight patients were recruited. Three patients 
were withdrawn due to unsuccessful first attempt 
intubation and one patient was dropped out due 
hypertension on beta-blocker discovered subsequently. 
The baseline characteristics including age, weight, 
BMI (body mass index), gender and ASA status were 
comparable (Table 1). 
Table 1: Patients‟ characteristics.  Values expressed as mean 
(SD) and number where appropriate. 
 
 
Table 2 showed changes in haemodynamic parameters 
with time. There were no significant changes over time 
in both groups compared to baseline. There were also 
no significant changes in between groups. There was 
no incidence of bradycardia seen in the remifentanil 
group, thus no vagolytic treatment needed for any of 
the patients in that group. Two patients in the fentanyl 
group experienced tachycardia for about 1 minute after 
intubation and needed deepening of anaesthesia using 
the volatile agent. 
 
In the Fentanyl group, the SBP and MAP were 
significantly lower after induction at the 3rd minute (p 
< 0.05), and again after intubation at the 5th minute (p 
< 0.05). DBP were lower than baseline significantly 
after induction at the 2nd and 3rd minutes and after 
intubation at the 4th to 5th minute. Throughout the 
entire study period, the SBP, MAP and DBP remained 
lower compared to baseline but not statistically 
significant. In the Remifentanil group, the SBP, MAP 
and DBP remained slightly lower than baseline 
throughout the whole study period. However, these 
changes were not statistically significant. 
 
Three patients in the fentanyl group and three patients 
in the remifentanil group experienced hypotension 
post induction and all patients needed only one bolus 
of ephedrine 3mg (13.6% each group) as treatment. 
Six patients (27.2%) in the fentanyl group and one 







Age (Year) 37.1(11.4) 38.9(10.9) 
Weight (kg) 66.7(11.4) 64.5(12.3) 
Height (cm) 168.91(7.4) 165.8(8.0) 
BMI (Body Mass Index) 23.2(2.7) 23.3(3.1) 
Race    
Malay 20 13 
Chinese 1 5 
Indian 1 3 
Others 0 1 
Gender    
Male 14 13 
Female 8 9 
ASA status    
I 17 19 
II 5 3 
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Table 2: Mean (SD) HR, SBP, MAP and DBP at baseline, after induction of anaesthesia (Ind) and after tracheal intubation (Int) in 
Group F and Group R.  P<0.05 compared to baseline. 
 
 Baseline Ind+ 1min Ind+ 2min Ind+ 3min Int + 1min Int + 2min Int + 3min Int + 4min Int + 5min 
Group F 
(n=22) 
         
HR 77 (10) 74 (8) 72(10) 69 (9) 82(17) 84 (19) 79 (17) 76 (15) 73 (13) 
SBP 130 (13) 118 (16) 112 (14) 106(16)* 122 (19) 124 (19) 116 (18) 110 (16) 109(12)* 
MAP 94 (11) 84 (12) 80 (10) 76 (10)* 88 (13) 90 (12) 84 (11) 79 (9) 78 (7)* 
DBP 76 (9) 67 (11) 64 (9)⃰ 60 (9)* 71 (12) 74 (10) 68 (10) 65 (8)* 63 (7)* 
Group R 
(n=22) 
         
HR 80 (11) 81 (11) 79 (10) 74 (9) 82 (11) 80 (12) 76 (10) 76 (10) 72 (10) 
SBP 119 (10) 113 (11) 107 (13) 105 (11) 116 (12) 113 (11) 110 (11) 108 (12) 107 (14) 
MAP 86 (6) 82 (6) 78 (8) 76 (6) 85 (8) 83 (8) 80 (9) 79 (8) 77 (10) 
DBP 71 (6) 66 (5) 63 (5) 62 (5) 70 (7) 68 (8) 66 (8) 65 (7) 63 (8) 
 
hypertension and required an increase in sevoflurane 




Laryngoscopy and endotracheal intubation are rapid, 
simple and safe airway management techniques which 
are routinely performed. However, both procedures 
produce noxious stimuli to the cardiovascular system 
in the practice of general anaesthesia (2). These 
adverse physiological responses pose major concerns 
for Anaesthesiologists as it can lead to traumatic 
complications. The cardiovascular response arises 
from sympathoadrenal reflexes (1). Coughing and 
„barking‟ also add to increased venous, intracranial 
and intraocular pressures. These haemodynamic 
changes, even though short-lived, can cause serious 
problems in patients with cardiovascular and cerebral 
status. In this study, we used opioids as an adjuvant 
therapy to reduce the hemodynamic responses during 
both procedures. In terms of induction agents, Edelist 
(1987) showed that propofol provided excellent 
intubation conditions in 97% of patients as compared 
to 80% in the thiopentone group (25). In addition, 
Martin et al. also showed that propofol reduces the 
remifentanil requirements in a synergistic manner (26). 
The use of the muscle relaxant, rocuronium at 0.6 
mg/kg, was to provide excellent quality of anaesthesia 
and suppression of laryngeal reflexes. Rocuronium 
does not affect the haemodynamic parameters as it is 
free of clinically significant cardiovascular side effects 
(27). 
 
From the present study, it was found that remifentanil 
of 0.5 mcg/kg bolus followed by 0.25 mcg/kg/min can 
be used safely as an adjuvant to attenuate 
cardiovascular responses during laryngoscopy and 
tracheal intubation for routine cases. Patients who may 
benefit from the use of remifentanil are those who can 
only tolerate minimal haemodynamic changes during 
laryngoscopy and tracheal intubation, e.g. patients 
with aneurysms, penetrating eye injury or 
cardiovascular disease with compromised function. 
However, further studies are needed to confirm the 
benefits of the use of remifentanil in these groups of 
patients. 
 
In this study, the incidence of hypotension requiring 
rescue medications were 13.6%, which was 
comparable to the study done by Hall et al. (28) Hogue 
et al. (29) and Kautto (30) which reported incidence of 
hypotension of 10%, 10% and 17% respectively. In the 
remifentanil group, only one patient (4.5%) 
experienced hypertension. Hogue et al. reported 25% 
incidence of hypertension associated with the use of 
remifentanil. 
 
Most of the multicentre studies reported the 
occurrence of bradycardia in patients receiving higher 
dosages of remifentanil (3). Hogue et al. (1996) 
reported an incidence of bradycardia in 7% of patients 
receiving 1 mcg/kg bolus followed by 0.5 mcg/kg/min; 
and 19% in patients receiving a bolus dose of 1 
mcg/kg followed by 1mcg/kg/min infusion (29). 
However, our results were comparable to the study 
done by Thompson and Rowbotham (1996) (15) who 
reported a lower incidence of bradycardia (5%) in 
patients who received a lower dosage of 0.5 mcg/kg 
bolus followed by 0.25 mcg/kg/min infusion. These 
patients did not require any vagolytic treatment. For 
studies using a higher dosage of 1mcg/kg bolus and 
0.5 mcg/kg/min infusion, most authors would give 
intravenous glycopyrrolate as a vagolytic agent as it 
was known that the incidence of bradycardia may be 
as high as 50% (3). In another study for patients, ASA 
II-III and in the elderly, an even lower dose of 
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remifentanil 0.5 mcg/kg bolus followed by 0.1 
mcg/kg/min was used, no incidence of bradycardia 
was reported and haemodynamic changes during 
laryngoscopy and endoctracheal intubation were 
successfully attenuated (19).  
  
Fentanyl is commonly used for attenuation of 
cardiovascular responses in which the dose used is 1-3 
mcg/kg bolus given prior to administration of 
induction agents. In this study, 2 mcg/kg bolus was 
used. Xue et al. (2008) concluded that 2 mcg/kg 
fentanyl suppresses the haemodynamic response to 
endotracheal intubation more than laryngoscopy (5). 
Kautto (1982) showed that induction with 2 mcg/kg 
fentanyl significantly prevented the undesirable 
increase in heart rate, arterial blood pressure and rate 
pressure product after laryngoscopy and intubation, 
and fentanyl 6 mcg/kg completely prevent adverse 
haemodynamic responses (30). However, 
unnecessarily large doses of fentanyl may lead to 
muscle rigidity, bradycardia, nausea, vomiting and 
may also cause prolonged respiratory depression 
postoperatively especially if the surgery duration is 
short. 
 
A limitation to this study would include this being a 
multi-operator study whereby the skill and experience 
of the Anaesthetist could have influenced the process 
of laryngoscopy and intubation. In conclusion, 
remifentanil 0.5 mcg/kg bolus followed by 0.25 
mcg/kg/min infusion resulted in SBP, MAP and DBP 
remained slightly lower than baseline throughout the 
entire period but still considered stable, as these 
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